Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $4.13 and traded as high as $5.07. Hypermarcas shares last traded at $4.95, with a volume of 773,806 shares.
Hypermarcas Trading Down 1.8%
The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. The firm has a market capitalization of $3.08 billion, a PE ratio of 20.23 and a beta of 0.79. The business's 50-day moving average price is $4.20 and its 200-day moving average price is $3.56.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $184.34 million for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Further Reading
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
